We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 52,509

What Is The Trump Pharmaceutical Policy?
  • Foley & Lardner LLP
  • USA
  • January 17 2017

Pharmaceutical stocks took a hit after President-elect Trump criticized the industry during his January 11, 2017 press conference. But he also


House, Senate Pass Budget Resolution in First Step Toward Repealing Obamacare
  • Squire Patton Boggs
  • USA
  • January 17 2017

Last week, Congress passed a budget resolution (S Con Res 3) that will serve as a first step in paving the way for budget reconciliation and eventual


What Is The Trump Pharmaceutical Policy?
  • Foley & Lardner LLP
  • USA
  • January 17 2017

Pharmaceutical stocks took a hit after President-elect Trump criticized the industry during his January 11, 2017 press conference. But he also


Medical Marijuana Comes to Pennsylvania: What to Expect As the Keystone State Rolls Out its New Medical Marijuana Program
  • K&L Gates
  • USA
  • January 17 2017

A lack of consensus regarding both medical and recreational marijuana has sparked intense debate across the country. Combined with federal law


FDA Issues Guidance for Classification Pathways for New Accessory Types
  • Squire Patton Boggs
  • USA
  • January 17 2017

Accessories to medical devices play an integral role for their parent medical devices, supporting or adding to the parent device’s functionality


Medicare Secondary Payer - A Lot Less Boring Now
  • Reed Smith LLP
  • USA
  • January 16 2017

We’ve previously written several posts (not recently) on Medicare secondary payer (“MSP”) issues - which we characterized as “boring.” The recent MSP


Supreme Court Will Judge Biosimilar Patent Dance
  • Foley & Lardner LLP
  • USA
  • January 16 2017

The U.S. Supreme Court has agreed to review some of the patent dispute resolution provisions of the Biologics Price Competition and Innovation Act


Part 2 of 3: The Telemedicine Debate in Texas: Teladoc Sues in Federal Court
  • Kane Russell Coleman & Logan PC
  • USA
  • January 16 2017

The rule issued by the Texas Medical Board requiring physicians to conduct a face-to-face or in-person visit with a patient in order to establish a


Michigan Midwifery License Legislation Signed into Law
  • Hall Render Killian Heath & Lyman PC
  • USA
  • January 16 2017

On January 3, 2017, Governor Rick Snyder signed House Bill 4598 (“HB 4598”) into law. HB 4598 adds Part 171 (Midwifery) to the Public Health Code and


CMS Finalizes Testing of New Episode Payment Models and MSSP Track 1 ACO
  • Ropes & Gray LLP
  • USA
  • January 13 2017

On January 3, 2017, CMS published a final rule addressing three care coordination models: Cardiac care: CMS added two new cardiac care episode